Prevention Works is a holistic approach to swine health built on our range of innovative world-class vaccines complemented by:
Our goal is going from prevention to prediction and beyond
The Swine Health content site. Curated for you with love.
“We know that vaccinating can decrease the amount of viruses in the air, so vaccination is a good mechanism to prevent airborne transmission” Swine veterinary consultant Dr. Carmen Alonso in Spain picks out lessons from her detailed studies of air samples inside and outside farms suffering an outbreak of PRRS, influenza A or porcine epidemic diarrhoea --- as well as poultry sites with highly pathogenic avian influenza.
Rutger Jansen
“Our recent work demonstrated the presence of the PCV-3 genome within mild-to moderate histological lesions of aborted fetuses.
In this video Dr. Mike Murtaugh discusses vaccine cross-protection on various PCV2 strains: PCV2a, PCV2b & PCV2d. He also talks about the outbreaks of PCVAD and how correct usage of the vaccine is key.
Prof Joaquim Segalés and Dr Oliver Duran Porcine circovirus type 2 (PCV2) was initially detected in the late 1990s in North America and Europe associated with a post weaning multisystemic wasting syndrome in pigs.
Greg Stevenson
Get the latest news on Swine Health Subscribe to our newsletter
US - Boehringer Ingelheim Vetmedica, Inc., (BIVI) has announced that the U.S. Animal and Plant Health Inspection Service has approved a duration of immunity (DOI) claim for Ingelvac® CircoFLEX™ of at least four months for porcine circovirus type 2 (PCV2), the primary pathogen for porcine circovirus associated disease (PCVAD).
Boehringer Ingelheim is proud to announce the 2nd Boehringer Ingelheim IPVS Ileitis symposium during the IPVS 2006 congress in Copenhagen. The Symposium will take place on July 17 from 16.45h - 18.00h at the Congress Centre; Auditorium 15.
Boehringer Ingelheim Vetmedica, Inc., last week transferred ownership of its Risk Assessment Program for porcine reproductive and respiratory syndrome (PRRS) to the American Association of swine Veterinarians (AASV).
EU - Since the launch of Boehringer's ileitis vaccine "Enterisol® Ileitis" in most European countries from September to November 2005, the oral ileitis vaccine has very quickly become firmly established in health maintenance and performance enhancement in pig production.
Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve pig’s weight gain and to reduce body weight variability. From now on, Enterisol® Ileitis is available in 19 European countries.